Target intelligence / Profile preview

Importin subunit alpha (KPNA)

Target
KPNA
Molecular classification
Karyopherin, Nuclear transport receptor, Adaptor protein
01

Overview

Importin subunit alpha (KPNA) is a family of adaptor proteins essential for the classical nuclear import pathway, which facilitates the translocation of proteins from the cytoplasm into the nucleus (Wikipedia, 2024). It functions by recognizing and binding to the nuclear localization signal (NLS) of cargo proteins through its armadillo (ARM) repeat domain, subsequently forming a ternary complex with importin subunit beta-1 (KPNB1) (NIH, 2015). This complex then interacts with the nuclear pore complex (NPC) to deliver the cargo into the nucleoplasm, where Ran-GTP binding triggers the release of the cargo (NIH, 2007). Beyond its role in normal cellular homeostasis, importin-α is frequently hijacked by various viruses, such as HIV-1, Influenza A, and SARS-CoV-2, to transport viral genomes or proteins into the host nucleus for replication (MDPI, 2018; NIH, 2023). In oncology, specific isoforms like KPNA2 are often overexpressed in multiple cancers, including breast and lung cancer, where they facilitate the nuclear entry of oncogenic transcription factors and serve as markers of poor prognosis (NIH, 2016). Therapeutic targeting of importin-α, notably by small molecules like ivermectin, aims to competitively inhibit the NLS-binding pocket, thereby blocking the nuclear import of viral and pro-tumorigenic proteins (Semantic Scholar, 2012).

Other names
Karyopherin alphaImportin alphaSRP1RCH1QIP1PTAC58KPNA1KPNA2KPNA3KPNA4KPNA5KPNA6KPNA7
02

Mechanism of action

Competitive inhibition of the nuclear localization signal (NLS) binding site on importin-α, preventing the formation of the importin-α/β/cargo ternary complex and subsequent translocation into the nucleus.

03

Biological functions

Nuclear importProtein transportTranscriptional regulationCell cycle regulationStress responseGametogenesis
04

Disease associations

Viral infectionCancerInflammation
05

Safety considerations

Inhibition of essential cellular protein transportPotential suppression of innate immune responses (e.g., STAT1/NF-κB import)
06

Interacting drugs

Ivermectin

2 more in the full profile.

07

Biomarkers

KPNA2 overexpressionNuclear localization of KPNA2

Beyond the preview

Go deeper on Importin subunit alpha (KPNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Importin subunit alpha (KPNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call